Skip to main content

Clinical

RSS  

Articles

  • When to Start ART?

    Data from a prospective cohort study demonstrate benefit from initiation of antiretroviral therapy at CD4 counts of 201-350/mm3. The possibility of benefit from initiation at even higher CD4 counts was also raised.
  • Special Feature: Communicable Diseases in Iraq

    The World Health Organization (WHO) profile of communicable diseases in Iraq was recently updated. The stated purpose of this publication is to provide public health professionals working in Iraq and neighboring countries with up-to-date information on the major communicable disease threats faced by the population.
  • Updates

    Extrapolating from epidemiological data, Watson and colleagues estimate that 1 in 300-500 travelers are asplenic.
  • Hormone therapy: Does it boost quality of life?

    New research from the Womens Health Initiative (WHI) indicates that for many postmenopausal women, combined hormone therapy does not have a clinically significant effect on their health-related quality of life.
  • Treatment options narrow for gonorrhea

    With fluoroquinolone-resistant gonorrhea becoming more common in the United States, clinicians have looked to two treatment alternatives, cefixime and ceftriaxone, to combat the sexually transmitted disease (STD).
  • Guest Column: New research confirms efficacy of NuvaRing

    Since the NuvaRing contraceptive vaginal ring (Organon, West Orange, NJ) entered the U.S. market in mid-2002, new research has been published that underscores its efficacy and acceptability.
  • Get ready to take cervical cancer screening to the next level

    It is estimated some 50 million women in the United States are screened on an annual basis with Pap tests. Clinicians now have another tool in their arsenal that will help distinguish women at increased risk of developing cervical cancer from those at very low risk.
  • FemCAP method receives market approval from the Food and Drug Administration

    Your next patient is a young married woman who is unable to use hormonal birth control and is not interested in using an intrauterine device. Because she wants to have more children, sterilization is not an option at the present time. What contraceptive methods are available to her?
  • Does EC impact contraceptive use?

    When it comes to emergency contraception (EC), does its availability and use impact ongoing contraceptive methods? Initial research from one study indicates that adolescent mothers who are given a supply of EC are no less likely to use condoms and other forms of birth control than teen mothers who are not given EC.
  • Pharmacology Watch: Warfarin Effectively Prevents Venous Thromboembolism

    Warfarin Effectively Prevents Venous Thromboembolism; Vitamin D Reduces Osteoporotic Fractures; Adefovir Effective for Hepatitis B Treatment; Ibuprofen/Aspirin Study Revisited; ACE Inhibitors Favored in Cardiovascular Care; Digoxin Dosing and Heart Failure